Dose Escalation Evaluation

Dose Escalation Evaluation is a methodological framework within pharmacokinetic and pharmacodynamic analysis that systematically assesses the relationship between increasing drug doses and corresponding changes in exposure metrics to determine dose-proportionality during clinical development.

734

Publications

38.1K

Citations

6.8K

Authors

1.7K

Institutions

Publications per year

2017–2026

265

Authors

6.8K

  1. HA
    Howard A. Burris

    Sarah Cannon, United States

    27 publications · 2.3K citations

    19

    h-index

  2. PL
    Patricia LoRusso

    The Barbara Ann Karmanos Cancer Institute, United States

    20 publications · 1.2K citations

    17

    h-index

  3. JT
    Josep Tabernero

    Vall d'Hebron Hospital Universitari, Spain

    14 publications · 1K citations

    14

    h-index

  4. JR
    Jeffrey R. Infante

    Sarah Cannon, United States

    13 publications · 944 citations

    12

    h-index

  5. AW
    Anthony W. Tolcher

    South Texas Accelerated Research Therapeutics, United States

    12 publications · 771 citations

    12

    h-index

1–5 of 6.8K

Venues

  1. Journal of Clinical Oncology

    159 publications · 8.2K citations

    44

    h-index

  2. Clinical Cancer Research

    46 publications · 4K citations

    34

    h-index

  3. PubMed

    Repository · 34 publications · 1.2K citations

    21

    h-index

  4. British Journal of Cancer

    BJC · 20 publications · 1K citations

    16

    h-index

  5. Blood

    18 publications · 668 citations

    15

    h-index

1–5